HSCS
HeartSciences Inc.
Price Chart
Latest Quote
$2.63
-0.12 (-4.36%)
Current Price
| Previous Close | $2.75 |
| Open | $2.78 |
| Day High | $2.89 |
| Day Low | $2.35 |
| Volume | 1,862,055 |
Stock Information
| Shares Outstanding | 3.29M |
| Total Debt | $3.87M |
| Cash Equivalents | $3.40M |
| Revenue | $9K |
| Net Income | $-8.49M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $8.65M |
| EPS (TTM) | $-4.49 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $8.81M |
| Sales | $9K |
| Income | $-8.49M |
| Book/sh | $0.83 |
| Cash/sh | $1.03 |
| Employees | 15 |
Financial Ratios
| Quick Ratio | 0.80 |
| Current Ratio | 1.19 |
| Debt/Eq | 145.81 |
Returns & Margins
| ROA | -73.51% |
| ROE | -382.32% |
| Gross Margin | 57.92% |
| Operating Margin | -89939.56% |
Ownership
| Insider Ownership | 2.34% |
| Institutional Ownership | 6.77% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.93 |
| P/S | 998.23 |
| P/B | 3.16 |
Analyst Data
| Recommendation | none |
| Target Price | $10.00 |
Technical Indicators
| SMA20 | $1.96 |
| SMA50 | $1.97 |
| SMA200 | $2.71 |
| RSI | 67.87 |
| ATR | 0.3000 |
| Shares Float | 3.07M |
| Short Float | 1.40% |
| Short Ratio | 1.82 |
| Volatility | 1.97 |
| Rel Volume | 0.27 |
Performance History
| Week | +39.15% |
| Month | +32.83% |
| Quarter | +8.23% |
| 6 Months | +11.44% |
| YTD | -16.24% |
| Year | -30.61% |
| 3 Years | -97.30% |
| 10 Years | -98.91% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $2.63 | 1,862,055 |
| 2026-06-23 | $2.75 | 135,744,900 |
| 2026-06-22 | $1.77 | 41,100 |
| 2026-06-18 | $1.84 | 49,500 |
| 2026-06-17 | $1.82 | 35,200 |
| 2026-06-16 | $1.89 | 25,500 |
| 2026-06-15 | $1.84 | 149,000 |
| 2026-06-12 | $1.80 | 31,200 |
| 2026-06-11 | $1.88 | 173,200 |
| 2026-06-10 | $1.88 | 29,500 |
| 2026-06-09 | $1.88 | 11,200 |
| 2026-06-08 | $1.84 | 23,700 |
| 2026-06-05 | $1.94 | 15,900 |
| 2026-06-04 | $2.01 | 9,700 |
| 2026-06-03 | $2.04 | 19,200 |
| 2026-06-02 | $2.07 | 112,100 |
| 2026-06-01 | $2.03 | 141,100 |
| 2026-05-29 | $1.67 | 54,800 |
| 2026-05-28 | $1.79 | 25,800 |
| 2026-05-27 | $1.80 | 49,200 |
| 2026-05-26 | $1.93 | 23,500 |
About HeartSciences Inc.
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,880 | $6,081 | $2,796 | $7,890 |
| Cost Of Revenue | $1,880 | $6,081 | $2,796 | $7,890 |
| Total Revenue | $4,350 | $18,600 | $5,150 | $14,373 |
| Operating Revenue | $4,350 | $18,600 | $5,150 | $14,373 |
| Expenses | ||||
| Interest Expense | $500,453 | $354,080 | $243,174 | $371,619 |
| Total Expenses | $8,356,921 | $6,324,370 | $6,118,114 | $4,723,772 |
| Other Income Expense | $87,795 | $54,642 | $1,848 | $252,758 |
| Other Non Operating Income Expenses | $87,795 | $54,642 | $1,848 | $2,558 |
| Net Non Operating Interest Income Expense | $-500,453 | $-354,080 | $-243,174 | $-371,619 |
| Interest Expense Non Operating | $500,453 | $354,080 | $243,174 | $371,619 |
| Operating Expense | $8,355,041 | $6,318,289 | $6,115,318 | $4,715,882 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-8,765,229 | $-6,605,208 | $-6,354,290 | $-4,828,260 |
| Net Interest Income | $-500,453 | $-354,080 | $-243,174 | $-371,619 |
| Normalized Income | $-8,765,229 | $-6,605,208 | $-6,354,290 | $-5,078,460 |
| Net Income From Continuing And Discontinued Operation | $-8,765,229 | $-6,605,208 | $-6,354,290 | $-4,828,260 |
| Total Operating Income As Reported | $-8,352,571 | $-6,305,770 | $-6,112,964 | $-4,709,399 |
| Net Income Common Stockholders | $-8,765,229 | $-6,605,208 | $-6,354,290 | $-4,828,260 |
| Net Income | $-8,765,229 | $-6,605,208 | $-6,354,290 | $-4,828,260 |
| Net Income Including Noncontrolling Interests | $-8,765,229 | $-6,605,208 | $-6,354,290 | $-4,828,260 |
| Net Income Continuous Operations | $-8,765,229 | $-6,605,208 | $-6,354,290 | $-4,828,260 |
| Pretax Income | $-8,765,229 | $-6,605,208 | $-6,354,290 | $-4,828,260 |
| Operating Income | $-8,352,571 | $-6,305,770 | $-6,112,964 | $-4,709,399 |
| Gross Profit | $2,470 | $12,519 | $2,354 | $6,483 |
| Special Income Charges | - | - | $0 | $250,200 |
| Per Share | ||||
| Diluted EPS | $-9.34 | $-18.74 | $-80.00 | $-59.52 |
| Basic EPS | $-9.34 | $-18.74 | $-80.00 | $-59.52 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-8,136,820 | $-6,155,995 | $-5,975,663 | $-4,680,275 |
| Reconciled Depreciation | $127,956 | $95,133 | $135,453 | $26,566 |
| EBITDA (Bullshit earnings) | $-8,136,820 | $-6,155,995 | $-5,975,663 | $-4,430,075 |
| EBIT | $-8,264,776 | $-6,251,128 | $-6,111,116 | $-4,456,641 |
| Diluted Average Shares | $938,257 | $352,520 | $79,506 | $81,121 |
| Basic Average Shares | $938,257 | $352,520 | $79,506 | $81,121 |
| Diluted NI Availto Com Stockholders | $-8,765,229 | $-6,605,208 | $-6,354,290 | $-4,828,260 |
| Research And Development | $4,386,105 | $2,878,554 | $2,460,868 | $3,001,532 |
| Selling General And Administration | $3,968,936 | $3,439,735 | $3,654,450 | $1,714,350 |
| Total Unusual Items | - | - | $0 | $250,200 |
| Total Unusual Items Excluding Goodwill | - | - | $0 | $250,200 |
| Gain On Sale Of Ppe | - | - | - | $0 |
| Other Special Charges | - | - | - | $-250,200 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,411,106 | $5,728,055 | $230,557 | $-6,055,796 |
| Total Assets | $4,222,909 | $9,503,113 | $3,287,233 | $2,089,448 |
| Total Non Current Assets | $2,051,452 | $2,149,220 | $590,652 | $158,570 |
| Goodwill And Other Intangible Assets | $1,616,277 | $1,589,246 | $0 | - |
| Current Assets | $2,171,457 | $7,353,893 | $2,696,581 | $1,930,878 |
| Other Current Assets | $40,374 | $40,374 | $40,374 | $40,374 |
| Current Deferred Assets | $290,925 | $692,988 | $175,921 | $246,400 |
| Prepaid Assets | $87,443 | $183,704 | $143,460 | $49,384 |
| Inventory | $650,267 | $629,179 | $676,359 | $674,139 |
| Receivables | $4,350 | $0 | $0 | $2,321 |
| Accounts Receivable | $4,350 | $0 | $0 | $2,321 |
| Cash Cash Equivalents And Short Term Investments | $1,098,098 | $5,807,648 | $1,660,467 | $918,260 |
| Cash And Cash Equivalents | $1,098,098 | $5,807,648 | $1,660,467 | $918,260 |
| Debt | ||||
| Net Debt | $1,453,072 | - | - | $5,153,547 |
| Total Debt | $2,985,215 | $1,036,338 | $1,565,870 | $6,162,775 |
| Long Term Debt And Capital Lease Obligation | $314,527 | $434,045 | $1,036,335 | $4,441,807 |
| Current Debt And Capital Lease Obligation | $2,670,688 | $602,293 | $529,535 | $1,720,968 |
| Current Debt | $2,551,170 | $500,000 | $500,000 | $1,630,000 |
| Other Current Borrowings | $2,551,170 | $500,000 | $500,000 | $1,630,000 |
| Long Term Debt | - | - | $500,000 | $4,441,807 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $4,017,738 | $2,185,812 | $3,056,676 | $8,145,244 |
| Total Non Current Liabilities Net Minority Interest | $314,527 | $434,045 | $1,223,785 | $4,674,675 |
| Current Liabilities | $3,703,211 | $1,751,767 | $1,832,891 | $3,470,569 |
| Other Current Liabilities | $29,927 | $34,147 | $48,596 | $1,220 |
| Payables And Accrued Expenses | $1,002,596 | $1,115,327 | $1,254,760 | $1,748,381 |
| Interest Payable | $177,628 | $268,813 | $237,534 | - |
| Payables | $318,661 | $448,183 | $631,369 | $694,745 |
| Accounts Payable | $318,661 | $448,183 | $631,369 | $694,745 |
| Equity | ||||
| Common Stock Equity | $204,791 | $7,316,921 | $230,176 | $-6,056,279 |
| Preferred Stock Equity | $380 | $380 | $381 | $483 |
| Total Equity Gross Minority Interest | $205,171 | $7,317,301 | $230,557 | $-6,055,796 |
| Stockholders Equity | $205,171 | $7,317,301 | $230,557 | $-6,055,796 |
| Retained Earnings | $-76,127,635 | $-67,362,406 | $-60,757,198 | $-54,402,908 |
| Other | ||||
| Ordinary Shares Number | $1,119,107 | $676,598 | $101,184 | $81,121 |
| Share Issued | $1,119,107 | $676,598 | $101,184 | $81,121 |
| Tangible Book Value | $-1,411,486 | $5,727,675 | $230,176 | $-6,056,279 |
| Invested Capital | $2,755,961 | $7,816,921 | $1,230,176 | $15,528 |
| Working Capital | $-1,531,754 | $5,602,126 | $863,690 | $-1,539,691 |
| Capital Lease Obligations | $434,045 | $536,338 | $565,870 | $90,968 |
| Total Capitalization | $205,171 | $7,317,301 | $730,557 | $-1,613,989 |
| Additional Paid In Capital | $76,331,307 | $74,678,650 | $60,987,273 | $48,343,305 |
| Capital Stock | $1,499 | $1,057 | $482 | $3,807 |
| Common Stock | $1,119 | $677 | $101 | $3,324 |
| Preferred Stock | $380 | $380 | $381 | $483 |
| Long Term Capital Lease Obligation | $314,527 | $434,045 | $536,335 | $0 |
| Current Capital Lease Obligation | $119,518 | $102,293 | $29,535 | $90,968 |
| Current Accrued Expenses | $683,935 | $667,144 | $623,391 | $1,053,636 |
| Net PPE | $435,175 | $559,974 | $590,652 | $158,570 |
| Accumulated Depreciation | $-537,358 | $-499,759 | $-471,867 | $-444,952 |
| Gross PPE | $972,533 | $1,059,733 | $1,062,519 | $603,522 |
| Leases | $32,812 | $32,812 | $32,812 | $32,812 |
| Other Properties | $837,158 | $924,358 | $927,144 | $468,147 |
| Machinery Furniture Equipment | $102,563 | $102,563 | $102,563 | $102,563 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-85,575 | $-85,575 | $-44,476 | $-81,446 |
| Finished Goods | $44,069 | $22,581 | $28,662 | $28,662 |
| Work In Process | $21,741 | $21,741 | $21,741 | $21,741 |
| Raw Materials | $670,032 | $670,432 | $670,432 | $705,182 |
| Non Current Accrued Expenses | - | $0 | $187,450 | $232,868 |
| Treasury Shares Number | - | - | $0 | - |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-7,443,182 | $-6,195,456 | $-5,791,885 | $-3,646,076 |
| Operating Activities | ||||
| Operating Cash Flow | $-7,412,994 | $-6,070,185 | $-5,773,577 | $-3,644,144 |
| Cash Flow From Continuing Operating Activities | $-7,412,994 | $-6,070,185 | $-5,773,577 | $-3,644,144 |
| Operating Gains Losses | - | - | - | $-227,310 |
| Investing Activities | ||||
| Capital Expenditure | $-30,188 | $-125,271 | $-18,308 | $-1,932 |
| Investing Cash Flow | $-30,188 | $-125,271 | $-18,308 | $-1,932 |
| Cash Flow From Continuing Investing Activities | $-30,188 | $-125,271 | $-18,308 | $-1,932 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $1,147,578 | $10,300,013 | $5,624,065 | $0 |
| Financing Cash Flow | $2,733,632 | $10,342,637 | $6,534,092 | $3,840,855 |
| Cash Flow From Continuing Financing Activities | $2,733,632 | $10,342,637 | $6,534,092 | $3,840,855 |
| Net Common Stock Issuance | $1,147,578 | $10,300,013 | $5,624,065 | $0 |
| Common Stock Issuance | $1,147,578 | $10,300,013 | $5,624,065 | $0 |
| Net Other Financing Charges | - | - | - | $-385,145 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-264,246 | $-291,625 | $-398,260 | $-500,000 |
| Issuance Of Debt | $1,850,300 | $334,249 | $0 | $4,726,000 |
| End Cash Position | $1,098,098 | $5,807,648 | $1,660,467 | $918,260 |
| Beginning Cash Position | $5,807,648 | $1,660,467 | $918,260 | $723,481 |
| Changes In Cash | $-4,709,550 | $4,147,181 | $742,207 | $194,779 |
| Net Issuance Payments Of Debt | $1,586,054 | $42,624 | $-398,260 | $4,226,000 |
| Net Long Term Debt Issuance | $1,586,054 | $42,624 | $-398,260 | $4,226,000 |
| Long Term Debt Payments | $-264,246 | $-291,625 | $-398,260 | $-500,000 |
| Long Term Debt Issuance | $1,850,300 | $334,249 | $0 | $4,726,000 |
| Net Intangibles Purchase And Sale | $-27,031 | $-60,816 | $0 | - |
| Purchase Of Intangibles | $-27,031 | $-60,816 | $0 | - |
| Net PPE Purchase And Sale | $-3,157 | $-64,455 | $-18,308 | $-1,932 |
| Purchase Of PPE | $-3,157 | $-64,455 | $-18,308 | $-1,932 |
| Change In Working Capital | $517,888 | $-504,363 | $65,446 | $1,124,745 |
| Change In Other Working Capital | $402,063 | $-517,067 | $60,432 | $-246,400 |
| Change In Other Current Liabilities | $-103,513 | $-29,532 | $-108,538 | - |
| Change In Payables And Accrued Expense | $-112,731 | $-241,876 | $-272,322 | $1,224,307 |
| Change In Accrued Expense | $16,791 | $-58,690 | $-310,146 | $865,343 |
| Change In Payable | $-129,522 | $-183,186 | $37,824 | $358,964 |
| Change In Account Payable | $-129,522 | $-183,186 | $37,824 | $358,964 |
| Change In Prepaid Assets | $357,507 | $236,932 | $385,773 | $72,524 |
| Change In Inventory | $-21,088 | $47,180 | $-2,220 | $76,635 |
| Change In Receivables | $-4,350 | $0 | $2,321 | $-2,321 |
| Changes In Account Receivables | $-4,350 | $0 | $2,321 | $-2,321 |
| Other Non Cash Items | $456,507 | $539,228 | $131,507 | $191,719 |
| Stock Based Compensation | $249,884 | $405,025 | $248,307 | $68,396 |
| Depreciation Amortization Depletion | $127,956 | $95,133 | $135,453 | $26,566 |
| Depreciation And Amortization | $127,956 | $95,133 | $135,453 | $26,566 |
| Depreciation | $127,956 | $95,133 | $135,453 | $26,566 |
| Net Income From Continuing Operations | $-8,765,229 | $-6,605,208 | $-6,354,290 | $-4,828,260 |
| Proceeds From Stock Option Exercised | - | $0 | $1,308,287 | $0 |
| Net Short Term Debt Issuance | - | - | - | $0 |
| Short Term Debt Issuance | - | - | - | $0 |
| Amortization Cash Flow | - | - | - | $0 |
| Amortization Of Intangibles | - | - | - | $0 |
| Gain Loss On Investment Securities | - | - | - | $22,890 |
| Gain Loss On Sale Of PPE | - | - | - | $0 |
| Sale Of PPE | - | - | - | - |
| Change In Other Current Assets | - | - | - | - |
Fetched: 2026-06-23